{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:59:12Z","timestamp":1784329152421,"version":"3.55.0"},"reference-count":232,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04837-x","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T21:02:43Z","timestamp":1765141363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Research progress on the role of mesenchymal stem cells in pyroptosis in sepsis"],"prefix":"10.1186","volume":"17","author":[{"given":"Xinqi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"4837_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"4837_CR2","doi-asserted-by":"crossref","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Volume 395. Lancet; 2020. pp. 200\u201311.","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"4837_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","volume":"46","author":"C Fleischmann-Struzek","year":"2020","unstructured":"Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, Allegranzi B, Reinhart K. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46:1552\u201362.","journal-title":"Intensive Care Med"},{"key":"4837_CR4","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"J Xie","year":"2020","unstructured":"Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, et al. The epidemiology of sepsis in Chinese icus: a National Cross-Sectional survey. Crit Care Med. 2020;48:e209-18.","journal-title":"Crit Care Med"},{"key":"4837_CR5","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMra2403213","volume":"391","author":"NJ Meyer","year":"2024","unstructured":"Meyer NJ, Prescott HC. Sepsis and septic shock. N Engl J Med. 2024;391:2133\u201346.","journal-title":"N Engl J Med"},{"key":"4837_CR6","doi-asserted-by":"publisher","first-page":"711939","DOI":"10.3389\/fimmu.2021.711939","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen W, Gong F, Chen Y, Chen E. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review. Front Immunol. 2021;12:711939.","journal-title":"Front Immunol"},{"key":"4837_CR7","volume":"72","author":"R Song","year":"2024","unstructured":"Song R, He S, Wu Y, Tan S. Pyroptosis in sepsis induced organ dysfunction. Curr Res Transl Med. 2024;72:103419.","journal-title":"Curr Res Transl Med"},{"key":"4837_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00266-6","volume":"43","author":"T Manzoor","year":"2023","unstructured":"Manzoor T, Saleem A, Farooq N, Dar LA, Nazir J, Saleem S, et al. Extracellular vesicles derived from mesenchymal stem cells - a novel therapeutic tool in infectious diseases. Inflamm Regen. 2023;43:17.","journal-title":"Inflamm Regen"},{"key":"4837_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11111160","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Song Y, Zeng Q, Jiang B. Mesenchymal stem cells and their extracellular vesicles are a promising alternative to antibiotics for treating sepsis. Bioengineering. 2024. https:\/\/doi.org\/10.3390\/bioengineering11111160.","journal-title":"Bioengineering"},{"key":"4837_CR10","doi-asserted-by":"publisher","first-page":"1338744","DOI":"10.3389\/fimmu.2024.1338744","volume":"15","author":"X Tao","year":"2024","unstructured":"Tao X, Wang J, Liu B, Cheng P, Mu D, Du H, et al. Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis. Front Immunol. 2024;15:1338744.","journal-title":"Front Immunol"},{"key":"4837_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00837-0","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X. Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol. 2025. https:\/\/doi.org\/10.1038\/s41580-025-00837-0.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4837_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277:61\u201375.","journal-title":"Immunol Rev"},{"key":"4837_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.it.2021.04.001","volume":"42","author":"D Tang","year":"2021","unstructured":"Tang D, Wang H, Billiar TR, Kroemer G, Kang R. Emerging mechanisms of immunocoagulation in sepsis and septic shock. Trends Immunol. 2021;42:508\u201322.","journal-title":"Trends Immunol"},{"key":"4837_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036392","author":"NM de Vasconcelos","year":"2020","unstructured":"de Vasconcelos NM, Lamkanfi M. Recent insights on inflammasomes, gasdermin pores, and pyroptosis. Cold Spring Harb Perspect Biol. 2020. https:\/\/doi.org\/10.1101\/cshperspect.a036392.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4837_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.","journal-title":"Signal Transduct Target Ther"},{"key":"4837_CR16","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1126\/science.1085536","volume":"300","author":"GM Barton","year":"2003","unstructured":"Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science. 2003;300:1524\u20135.","journal-title":"Science"},{"key":"4837_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nri2936","volume":"11","author":"M Lamkanfi","year":"2011","unstructured":"Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol. 2011;11:213\u201320.","journal-title":"Nat Rev Immunol"},{"key":"4837_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21:677\u201387.","journal-title":"Nat Med"},{"key":"4837_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-032712-095944","volume":"31","author":"J von Moltke","year":"2013","unstructured":"von Moltke J, Ayres JS, Kofoed EM, Chavarr\u00eda-Smith J, Vance RE. Recognition of bacteria by inflammasomes. Annu Rev Immunol. 2013;31:73\u2013106.","journal-title":"Annu Rev Immunol"},{"key":"4837_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13:397\u2013411.","journal-title":"Nat Rev Immunol"},{"key":"4837_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","volume":"40","author":"Y Xue","year":"2019","unstructured":"Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM. Emerging activators and regulators of inflammasomes and pyroptosis. Trends Immunol. 2019;40:1035\u201352.","journal-title":"Trends Immunol"},{"key":"4837_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18:1141\u201360.","journal-title":"Cell Mol Immunol"},{"key":"4837_CR23","doi-asserted-by":"publisher","first-page":"1114917","DOI":"10.3389\/fimmu.2023.1114917","volume":"14","author":"C Zhu","year":"2023","unstructured":"Zhu C, Liang Y, Luo Y, Ma X. Role of pyroptosis in hemostasis activation in sepsis. Front Immunol. 2023;14:1114917.","journal-title":"Front Immunol"},{"key":"4837_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.mib.2013.04.004","volume":"16","author":"Y Aachoui","year":"2013","unstructured":"Aachoui Y, Sagulenko V, Miao EA, Stacey KJ. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection. Curr Opin Microbiol. 2013;16:319\u201326.","journal-title":"Curr Opin Microbiol"},{"key":"4837_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2019.04.017","volume":"51","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang C, Yang J, Zhou B, Yang R, Ramachandran R, et al. Crystal structures of the full-length murine and human Gasdermin D reveal mechanisms of autoinhibition, lipid binding, and oligomerization. Immunity. 2019;51:43-49.e44.","journal-title":"Immunity"},{"key":"4837_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","volume":"35","author":"P Broz","year":"2025","unstructured":"Broz P. Pyroptosis: molecular mechanisms and roles in disease. Cell Res. 2025;35:334\u201344.","journal-title":"Cell Res"},{"key":"4837_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll RC, Schroder K, Pelegr\u00edn P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43:653\u201368.","journal-title":"Trends Pharmacol Sci"},{"key":"4837_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"J Shi","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514:187\u201392.","journal-title":"Nature"},{"key":"4837_CR29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41467-018-03409-3","volume":"9","author":"LH Chu","year":"2018","unstructured":"Chu LH, Indramohan M, Ratsimandresy RA, Gangopadhyay A, Morris EP, Monack DM, Dorfleutner A, Stehlik C. The oxidized phospholipid OxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun. 2018;9:996.","journal-title":"Nat Commun"},{"key":"4837_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245\u201354.","journal-title":"Trends Biochem Sci"},{"key":"4837_CR31","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/eji.201545772","volume":"45","author":"S R\u00fchl","year":"2015","unstructured":"R\u00fchl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 2015;45:2927\u201336.","journal-title":"Eur J Immunol"},{"key":"4837_CR32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/eji.201545523","volume":"45","author":"JL Schmid-Burgk","year":"2015","unstructured":"Schmid-Burgk JL, Gaidt MM, Schmidt T, Ebert TS, Bartok E, Hornung V. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur J Immunol. 2015;45:2911\u20137.","journal-title":"Eur J Immunol"},{"key":"4837_CR33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41418-019-0366-x","volume":"27","author":"D Wang","year":"2020","unstructured":"Wang D, Zheng J, Hu Q, Zhao C, Chen Q, Shi P, Chen Q, Zou Y, Zou D, Liu Q, Pei J, Wu X, Gao X, Ren J, Lin Z. Magnesium protects against sepsis by blocking gasdermin D N-terminal-induced pyroptosis. Cell Death Differ. 2020;27:466\u201381.","journal-title":"Cell Death Differ"},{"key":"4837_CR34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","volume":"49","author":"M Deng","year":"2018","unstructured":"Deng M, Tang Y, Li W, Wang X, Zhang R, Zhang X, et al. The endotoxin delivery protein HMGB1 mediates Caspase-11-dependent lethality in sepsis. Immunity. 2018;49:740-753.e747.","journal-title":"Immunity"},{"key":"4837_CR35","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","volume":"165","author":"SK Vanaja","year":"2016","unstructured":"Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, Rathinam VAK. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and Caspase-11 activation. Cell. 2016;165:1106\u201319.","journal-title":"Cell"},{"key":"4837_CR36","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104926","volume":"39","author":"M Kutsch","year":"2020","unstructured":"Kutsch M, Sistemich L, Lesser CF, Goldberg MB, Herrmann C, Coers J. Direct binding of polymeric GBP1 to LPS disrupts bacterial cell envelope functions. EMBO J. 2020;39:e104926.","journal-title":"EMBO J"},{"key":"4837_CR37","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1038\/s41467-020-16889-z","volume":"11","author":"JC Santos","year":"2020","unstructured":"Santos JC, Boucher D, Schneider LK, Demarco B, Dilucca M, Shkarina K, Heilig R, Chen KW, Lim RYH, Broz P. Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria. Nat Commun. 2020;11:3276.","journal-title":"Nat Commun"},{"key":"4837_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.immuni.2015.10.009","volume":"43","author":"D Yang","year":"2015","unstructured":"Yang D, He Y, Mu\u00f1oz-Planillo R, Liu Q, N\u00fa\u00f1ez G. Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity. 2015;43:923\u201332.","journal-title":"Immunity"},{"key":"4837_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111\u20136.","journal-title":"Nature"},{"key":"4837_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"4837_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41419-020-2476-2","volume":"11","author":"L Hu","year":"2020","unstructured":"Hu L, Chen M, Chen X, Zhao C, Fang Z, Wang H, Dai H. Chemotherapy-induced pyroptosis is mediated by BAK\/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate. Cell Death Dis. 2020;11:281.","journal-title":"Cell Death Dis"},{"key":"4837_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-019-1441-4","volume":"10","author":"J Yu","year":"2019","unstructured":"Yu J, Li S, Qi J, Chen Z, Wu Y, Guo J, Wang K, Sun X, Zheng J. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis. 2019;10:193.","journal-title":"Cell Death Dis"},{"key":"4837_CR43","doi-asserted-by":"publisher","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","volume":"115","author":"J Sarhan","year":"2018","unstructured":"Sarhan J, Liu BC, Muendlein HI, Li P, Nilson R, Tang AY, Rongvaux A, Bunnell SC, Shao F, Green DR, Poltorak A. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during yersinia infection. Proc Natl Acad Sci U S A. 2018;115:E10888\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4837_CR44","doi-asserted-by":"crossref","unstructured":"Schwarzer R, Jiao H, Wachsmuth L, Tresch A, Pasparakis M. FADD and Caspase-8 Regulate Gut Homeostasis and Inflammation by Controlling MLKL- and GSDMD-Mediated Death of Intestinal Epithelial Cells, Immunity, 52 (2020) 978\u2013993.e976.","DOI":"10.1016\/j.immuni.2020.04.002"},{"key":"4837_CR45","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu JM, Nie L, Chen Y, Wang YC, Liu C, Wang WJ, Wu Y, Ke B, Hsu JL, Huang K, Ye Z, Yang Y, Xia X, Li Y, Li CW, Shao B, Tainer JA, Hung MC. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22:1264\u201375.","journal-title":"Nat Cell Biol"},{"key":"4837_CR46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch M, G\u00fcnther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H, Seeger JM, Lamkanfi M, Kr\u00f6nke M, Pasparakis M, Kashkar H. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575:683\u20137.","journal-title":"Nature"},{"key":"4837_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41590-022-01386-w","volume":"24","author":"YY Chao","year":"2023","unstructured":"Chao YY, Puhach A, Frieser D, Arunkumar M, Lehner L, Seeholzer T, et al. Human T(H)17 cells engage gasdermin E pores to release IL-1\u03b1 on NLRP3 inflammasome activation. Nat Immunol. 2023;24:295\u2013308.","journal-title":"Nat Immunol"},{"key":"4837_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aax7969","author":"Y Liu","year":"2020","unstructured":"Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020. https:\/\/doi.org\/10.1126\/sciimmunol.aax7969.","journal-title":"Sci Immunol"},{"key":"4837_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, Junqueira C, Meza-Sosa KF, Mok TMY, Ansara J, Sengupta S, Yao Y, Wu H, Lieberman J. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415\u201320.","journal-title":"Nature"},{"key":"4837_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7548","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020. https:\/\/doi.org\/10.1126\/science.aaz7548.","journal-title":"Science"},{"key":"4837_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg3196","volume":"8","author":"Q Kong","year":"2023","unstructured":"Kong Q, Xia S, Pan X, Ye K, Li Z, Li H, et al. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023;8:eadg3196.","journal-title":"Sci Immunol"},{"key":"4837_CR52","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"4837_CR53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/15548627.2016.1179410","volume":"12","author":"J Ho","year":"2016","unstructured":"Ho J, Yu J, H Wong S, Zhang L, Liu X, T Wong W, C Leung C, Choi G, H Wang M, Gin T, T Chan M, K Wu W. Autophagy in sepsis: degradation into exhaustion? Autophagy. 2016;12:1073\u201382.","journal-title":"Autophagy"},{"key":"4837_CR54","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1056\/NEJMoa1415236","volume":"372","author":"KM Kaukonen","year":"2015","unstructured":"Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372:1629\u201338.","journal-title":"N Engl J Med"},{"key":"4837_CR55","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"4837_CR56","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ni.1960","volume":"11","author":"EA Miao","year":"2010","unstructured":"Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A, Warren SE, Wewers MD, Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010;11:1136\u201342.","journal-title":"Nat Immunol"},{"key":"4837_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nri.2016.147","volume":"17","author":"I Jorgensen","year":"2017","unstructured":"Jorgensen I, Rayamajhi M, Miao EA. Programmed cell death as a defence against infection. Nat Rev Immunol. 2017;17:151\u201364.","journal-title":"Nat Rev Immunol"},{"key":"4837_CR58","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1126\/science.1230751","volume":"339","author":"Y Aachoui","year":"2013","unstructured":"Aachoui Y, Leaf IA, Hagar JA, Fontana MF, Campos CG, Zak DE, Tan MH, Cotter PA, Vance RE, Aderem A, Miao EA. Caspase-11 protects against bacteria that escape the vacuole. Science. 2013;339:975\u20138.","journal-title":"Science"},{"key":"4837_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1189\/jlb.0912437","volume":"93","author":"M Aziz","year":"2013","unstructured":"Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013;93:329\u201342.","journal-title":"J Leukoc Biol"},{"key":"4837_CR60","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594\u2013605.","journal-title":"JAMA"},{"key":"4837_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479:117\u201321.","journal-title":"Nature"},{"key":"4837_CR62","doi-asserted-by":"publisher","first-page":"e1526","DOI":"10.1038\/cddis.2014.488","volume":"5","author":"M Aziz","year":"2014","unstructured":"Aziz M, Jacob A, Wang P. Revisiting caspases in sepsis. Cell Death Dis. 2014;5:e1526.","journal-title":"Cell Death Dis"},{"key":"4837_CR63","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","volume":"38","author":"RA Aglietti","year":"2017","unstructured":"Aglietti RA, Dueber EC. Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions. Trends Immunol. 2017;38:261\u201371.","journal-title":"Trends Immunol"},{"key":"4837_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bcp.2017.05.015","volume":"140","author":"A Pfalzgraff","year":"2017","unstructured":"Pfalzgraff A, Heinbockel L, Su Q, Brandenburg K, Weindl G. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses. Biochem Pharmacol. 2017;140:64\u201372.","journal-title":"Biochem Pharmacol"},{"key":"4837_CR65","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12951-024-02708-w","volume":"22","author":"X Liang","year":"2024","unstructured":"Liang X, Miao Y, Tong X, Chen J, Liu H, He Z, Liu A, Hu Z. Dental pulp mesenchymal stem cell-derived exosomes inhibit neuroinflammation and microglial pyroptosis in subarachnoid hemorrhage via the miRNA-197-3p\/FOXO3 axis. J Nanobiotechnol. 2024;22:426.","journal-title":"J Nanobiotechnol"},{"key":"4837_CR66","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fimmu.2020.01722","volume":"11","author":"V Kumar","year":"2020","unstructured":"Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 2020;11:1722.","journal-title":"Front Immunol"},{"key":"4837_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2501279","volume":"2022","author":"H Song","year":"2022","unstructured":"Song H, Yang B, Li Y, Qian A, Kang Y, Shan X. Focus on the mechanisms and functions of pyroptosis, inflammasomes, and inflammatory caspases in infectious diseases. Oxid Med Cell Longev. 2022;2022:2501279.","journal-title":"Oxid Med Cell Longev"},{"key":"4837_CR68","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1002\/jcp.27909","volume":"234","author":"X Xia","year":"2019","unstructured":"Xia X, Wang X, Zheng Y, Jiang J, Hu J. What role does pyroptosis play in microbial infection? J Cell Physiol. 2019;234:7885\u201392.","journal-title":"J Cell Physiol"},{"key":"4837_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040897","author":"JW Lee","year":"2021","unstructured":"Lee JW, Chun W, Lee HJ, Min JH, Kim SM, Seo JY, et al. The role of macrophages in the development of acute and chronic inflammatory lung diseases. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10040897.","journal-title":"Cells"},{"key":"4837_CR70","doi-asserted-by":"publisher","first-page":"e1009358","DOI":"10.1371\/journal.ppat.1009358","volume":"17","author":"B Briard","year":"2021","unstructured":"Briard B, Malireddi RKS, Kanneganti TD. Role of inflammasomes\/pyroptosis and PANoptosis during fungal infection. PLoS Pathog. 2021;17:e1009358.","journal-title":"PLoS Pathog"},{"key":"4837_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.molimm.2021.04.002","volume":"135","author":"P Jiang","year":"2021","unstructured":"Jiang P, Jin Y, Sun M, Jiang X, Yang J, Lv X, Wen Z. Extracellular histones aggravate inflammation in ARDS by promoting alveolar macrophage pyroptosis. Mol Immunol. 2021;135:53\u201361.","journal-title":"Mol Immunol"},{"key":"4837_CR72","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2147\/JIR.S304492","volume":"14","author":"N Li","year":"2021","unstructured":"Li N, Xiong R, He R, Liu B, Wang B, Geng Q. Mangiferin mitigates lipopolysaccharide-induced lung injury by inhibiting NLRP3 inflammasome activation. J Inflamm Res. 2021;14:2289\u2013300.","journal-title":"J Inflamm Res"},{"key":"4837_CR73","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.4103\/0366-6999.166039","volume":"128","author":"DD Wu","year":"2015","unstructured":"Wu DD, Pan PH, Liu B, Su XL, Zhang LM, Tan HY, et al. Inhibition of alveolar macrophage pyroptosis reduces lipopolysaccharide-induced acute lung injury in mice. Chin Med J (Engl). 2015;128:2638\u201345.","journal-title":"Chin Med J (Engl)"},{"key":"4837_CR74","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.omtn.2019.08.028","volume":"18","author":"Y Ying","year":"2019","unstructured":"Ying Y, Mao Y, Yao M. NLRP3 inflammasome activation by MicroRNA-495 promoter methylation May contribute to the progression of acute lung injury. Mol Ther Nucleic Acids. 2019;18:801\u201314.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4837_CR75","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.4049\/jimmunol.1601196","volume":"198","author":"Q Pu","year":"2017","unstructured":"Pu Q, Gan C, Li R, Li Y, Tan S, Li X, Wei Y, Lan L, Deng X, Liang H, Ma F, Wu M. Atg7 deficiency intensifies inflammasome activation and pyroptosis in Pseudomonas sepsis. J Immunol. 2017;198:3205\u201313.","journal-title":"J Immunol"},{"key":"4837_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2016-209170","volume":"72","author":"RL Zemans","year":"2017","unstructured":"Zemans RL, Matthay MA. What drives neutrophils to the alveoli in ARDS? Thorax. 2017;72:1\u20133.","journal-title":"Thorax"},{"key":"4837_CR77","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2147\/JIR.S259633","volume":"13","author":"Y Peng","year":"2020","unstructured":"Peng Y, Wu Q, Tang H, Chen J, Wu Q, Yuan X, Xiong S, Ye Y, Lv H. NLRP3 regulated CXCL12 expression in acute neutrophilic lung injury. J Inflamm Res. 2020;13:377\u201386.","journal-title":"J Inflamm Res"},{"key":"4837_CR78","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134\u201347.","journal-title":"Nat Rev Immunol"},{"key":"4837_CR79","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ejphar.2018.07.005","volume":"833","author":"Y Liang","year":"2018","unstructured":"Liang Y, Pan B, Alam HB, Deng Q, Wang Y, Chen E, et al. Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia. Eur J Pharmacol. 2018;833:432\u201340.","journal-title":"Eur J Pharmacol"},{"key":"4837_CR80","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2147\/JIR.S321513","volume":"14","author":"H Li","year":"2021","unstructured":"Li H, Li Y, Song C, Hu Y, Dai M, Liu B, Pan P. Neutrophil extracellular traps augmented alveolar macrophage pyroptosis via AIM2 inflammasome activation in LPS-Induced ALI\/ARDS. J Inflamm Res. 2021;14:4839\u201358.","journal-title":"J Inflamm Res"},{"key":"4837_CR81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.celrep.2014.06.028","volume":"8","author":"KW Chen","year":"2014","unstructured":"Chen KW, Gro\u00df CJ, Sotomayor FV, Stacey KJ, Tschopp J, Sweet MJ, Schroder K. The neutrophil NLRC4 inflammasome selectively promotes IL-1\u03b2 maturation without pyroptosis during acute Salmonella challenge. Cell Rep. 2014;8:570\u201382.","journal-title":"Cell Rep"},{"key":"4837_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107967","volume":"32","author":"SB Kovacs","year":"2020","unstructured":"Kovacs SB, Oh C, Maltez VI, McGlaughon BD, Verma A, Miao EA, et al. Neutrophil Caspase-11 is essential to defend against a cytosol-invasive bacterium. Cell Rep. 2020;32:107967.","journal-title":"Cell Rep"},{"key":"4837_CR83","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1164\/rccm.200410-1325OC","volume":"172","author":"EL Burnham","year":"2005","unstructured":"Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med. 2005;172:854\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"4837_CR84","doi-asserted-by":"publisher","first-page":"e2363","DOI":"10.1038\/cddis.2016.274","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang J, Zhao Y, Zhang P, Li Y, Yang Y, Yang Y, Zhu J, Song X, Jiang G, Fan J. Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS. Cell Death Dis. 2016;7:e2363.","journal-title":"Cell Death Dis"},{"key":"4837_CR85","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41419-018-0412-5","volume":"9","author":"D Lai","year":"2018","unstructured":"Lai D, Tang J, Chen L, Fan EK, Scott MJ, Li Y, Billiar TR, Wilson MA, Fang X, Shu Q, Fan J. Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis. Cell Death Dis. 2018;9:369.","journal-title":"Cell Death Dis"},{"key":"4837_CR86","doi-asserted-by":"publisher","first-page":"e1007105","DOI":"10.1371\/journal.ppat.1007105","volume":"14","author":"J Wang","year":"2018","unstructured":"Wang J, Sahoo M, Lantier L, Warawa J, Cordero H, Deobald K, Re F. Caspase-11-dependent pyroptosis of lung epithelial cells protects from melioidosis while caspase-1 mediates macrophage pyroptosis and production of IL-18. PLoS Pathog. 2018;14:e1007105.","journal-title":"PLoS Pathog"},{"key":"4837_CR87","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1172\/JCI94495","volume":"127","author":"KT Cheng","year":"2017","unstructured":"Cheng KT, Xiong S, Ye Z, Hong Z, Di A, Tsang KM, Gao X, An S, Mittal M, Vogel SM, Miao EA, Rehman J, Malik AB. Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury. J Clin Invest. 2017;127:4124\u201335.","journal-title":"J Clin Invest"},{"key":"4837_CR88","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2020.02.002","volume":"52","author":"LS Huang","year":"2020","unstructured":"Huang LS, Hong Z, Wu W, Xiong S, Zhong M, Gao X, et al. mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity. 2020;52:475-486.e475.","journal-title":"Immunity"},{"key":"4837_CR89","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/JIR.S374117","volume":"15","author":"CF Bi","year":"2022","unstructured":"Bi CF, Liu J, Yang LS, Zhang JF. Research progress on the mechanism of sepsis induced myocardial injury. J Inflamm Res. 2022;15:4275\u201390.","journal-title":"J Inflamm Res"},{"key":"4837_CR90","first-page":"30","volume":"3","author":"X Lv","year":"2016","unstructured":"Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 2016;3:30.","journal-title":"Mil Med Res"},{"key":"4837_CR91","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/jcsm.12763","volume":"12","author":"K Busch","year":"2021","unstructured":"Busch K, Kny M, Huang N, Klassert TE, Stock M, Hahn A, Graeger S, Todiras M, Schmidt S, Chamling B, Willenbrock M, Gro\u00df S, Biedenweg D, Heuser A, Scheidereit C, Butter C, Felix SB, Otto O, Luft FC, Slevogt H, Fielitz J. Inhibition of the NLRP3\/IL-1\u03b2 axis protects against sepsis-induced cardiomyopathy. J Cachexia Sarcopenia Muscle. 2021;12:1653\u201368.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4837_CR92","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1096\/fj.201600728R","volume":"30","author":"M Kalbitz","year":"2016","unstructured":"Kalbitz M, Fattahi F, Grailer JJ, Jajou L, Malan EA, Zetoune FS, et al. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis. FASEB J. 2016;30:3997\u20134006.","journal-title":"FASEB J"},{"key":"4837_CR93","doi-asserted-by":"publisher","first-page":"tkac043","DOI":"10.1093\/burnst\/tkac043","volume":"10","author":"C Song","year":"2022","unstructured":"Song C, Zhang Y, Pei Q, Zheng L, Wang M, Shi Y, Wu S, Ni W, Fu X, Peng Y, Zhang W, Yao M. HSP70 alleviates sepsis-induced cardiomyopathy by attenuating mitochondrial dysfunction-initiated NLRP3 inflammasome-mediated pyroptosis in cardiomyocytes. Burns Trauma. 2022;10:tkac043.","journal-title":"Burns Trauma"},{"key":"4837_CR94","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1002\/ptr.7191","volume":"35","author":"S Dai","year":"2021","unstructured":"Dai S, Ye B, Chen L, Hong G, Zhao G, Lu Z. Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation. Phytother Res. 2021;35:5203\u201313.","journal-title":"Phytother Res"},{"key":"4837_CR95","doi-asserted-by":"publisher","first-page":"174438","DOI":"10.1016\/j.ejphar.2021.174438","volume":"909","author":"P Chen","year":"2021","unstructured":"Chen P, An Q, Huang Y, Zhang M, Mao S. Prevention of endotoxin-induced cardiomyopathy using sodium Tanshinone IIA sulfonate: involvement of augmented autophagy and NLRP3 inflammasome suppression. Eur J Pharmacol. 2021;909:174438.","journal-title":"Eur J Pharmacol"},{"key":"4837_CR96","doi-asserted-by":"publisher","first-page":"779432","DOI":"10.3389\/fcell.2021.779432","volume":"9","author":"S Dai","year":"2021","unstructured":"Dai S, Ye B, Zhong L, Chen Y, Hong G, Zhao G, et al. GSDMD mediates LPS-induced septic myocardial dysfunction by regulating ROS-dependent NLRP3 inflammasome activation. Front Cell Dev Biol. 2021;9:779432.","journal-title":"Front Cell Dev Biol"},{"key":"4837_CR97","doi-asserted-by":"publisher","first-page":"121743","DOI":"10.1016\/j.lfs.2023.121743","volume":"324","author":"S Joshi","year":"2023","unstructured":"Joshi S, Kundu S, Priya VV, Kulhari U, Mugale MN, Sahu BD. Anti-inflammatory activity of carvacrol protects the heart from lipopolysaccharide-induced cardiac dysfunction by inhibiting pyroptosis via NLRP3\/Caspase1\/Gasdermin D signaling axis. Life Sci. 2023;324:121743.","journal-title":"Life Sci"},{"key":"4837_CR98","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.freeradbiomed.2024.02.026","volume":"215","author":"WW Zhang","year":"2024","unstructured":"Zhang WW, Wang SS, Ding YD, Wu XY, Chen T, Gao Y, Jin SW, Zhang PH. Cardiac resolvin D2 ameliorates sepsis-induced cardiomyopathy via inhibiting Caspase-11\/GSDMD dependent pyroptosis. Free Radic Biol Med. 2024;215:64\u201376.","journal-title":"Free Radic Biol Med"},{"key":"4837_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2022.07.005","volume":"171","author":"Y Gao","year":"2022","unstructured":"Gao Y, Shi H, Dong Z, Zhang F, Sun A, Ge J. Current knowledge of pyroptosis in heart diseases. J Mol Cell Cardiol. 2022;171:81\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"4837_CR100","doi-asserted-by":"publisher","first-page":"e107639","DOI":"10.1371\/journal.pone.0107639","volume":"9","author":"W Zhang","year":"2014","unstructured":"Zhang W, Xu X, Kao R, Mele T, Kvietys P, Martin CM, Rui T. Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS ONE. 2014;9:e107639.","journal-title":"PLoS ONE"},{"key":"4837_CR101","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.120.318075","volume":"129","author":"J Rong","year":"2021","unstructured":"Rong J, Tao X, Lin Y, Zheng H, Ning L, Lu HS, Daugherty A, Shi P, Mullick AE, Chen S, Zhang Z, Xu Y, Wang J. Loss of hepatic angiotensinogen attenuates Sepsis-Induced myocardial dysfunction. Circ Res. 2021;129:547\u201364.","journal-title":"Circ Res"},{"key":"4837_CR102","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10753-017-0706-2","volume":"41","author":"D Wu","year":"2018","unstructured":"Wu D, Shi L, Li P, Ni X, Zhang J, Zhu Q, et al. Intermedin(1\u201353) protects cardiac fibroblasts by inhibiting NLRP3 inflammasome activation during sepsis. Inflammation. 2018;41:505\u201314.","journal-title":"Inflammation"},{"key":"4837_CR103","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00395-017-0603-8","volume":"112","author":"W Zhang","year":"2017","unstructured":"Zhang W, Tao A, Lan T, Cepinskas G, Kao R, Martin CM, Rui T. Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts. Basic Res Cardiol. 2017;112:16.","journal-title":"Basic Res Cardiol"},{"key":"4837_CR104","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cardfail.2015.01.002","volume":"21","author":"B Zhang","year":"2015","unstructured":"Zhang B, Liu Y, Sui YB, Cai HQ, Liu WX, Zhu M, Yin XH. Cortistatin inhibits NLRP3 inflammasome activation of cardiac fibroblasts during sepsis. J Card Fail. 2015;21:426\u201333.","journal-title":"J Card Fail"},{"key":"4837_CR105","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18:424\u201334.","journal-title":"Nat Rev Cardiol"},{"key":"4837_CR106","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1002\/jcp.30186","volume":"236","author":"L Wang","year":"2021","unstructured":"Wang L, Zhao H, Xu H, Liu X, Chen X, Peng Q, Xiao M. Targeting the TXNIP-NLRP3 interaction with PSSM1443 to suppress inflammation in sepsis-induced myocardial dysfunction. J Cell Physiol. 2021;236:4625\u201339.","journal-title":"J Cell Physiol"},{"key":"4837_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107544","volume":"26","author":"M Zhao","year":"2023","unstructured":"Zhao M, Zheng Z, Zhang P, Xu Y, Zhang J, Peng S, et al. IL-30 protects against sepsis-induced myocardial dysfunction by inhibiting pro-inflammatory macrophage polarization and pyroptosis. iScience. 2023;26:107544.","journal-title":"iScience"},{"key":"4837_CR108","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4837_CR109","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/01.CCM.0000259462.97164.A0","volume":"35","author":"L Kramer","year":"2007","unstructured":"Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Incidence and prognosis of early hepatic dysfunction in critically ill patients\u2013a prospective multicenter study. Crit Care Med. 2007;35:1099\u2013104.","journal-title":"Crit Care Med"},{"key":"4837_CR110","first-page":"5685","volume":"8","author":"YL Chen","year":"2016","unstructured":"Chen YL, Xu G, Liang X, Wei J, Luo J, Chen GN, Yan XD, Wen XP, Zhong M, Lv X. Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. Am J Transl Res. 2016;8:5685\u201395.","journal-title":"Am J Transl Res"},{"key":"4837_CR111","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1269747","volume":"2022","author":"Z Li","year":"2022","unstructured":"Li Z, Liu T, Feng Y, Tong Y, Jia Y, Wang C, et al. PPAR\u03b3 alleviates sepsis-induced liver injury by inhibiting hepatocyte pyroptosis via inhibition of the ROS\/TXNIP\/NLRP3 signaling pathway. Oxid Med Cell Longev. 2022;2022:1269747.","journal-title":"Oxid Med Cell Longev"},{"key":"4837_CR112","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","volume":"55","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity. 2022;55:1515\u201329.","journal-title":"Immunity"},{"key":"4837_CR113","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","volume":"66","author":"X Yu","year":"2017","unstructured":"Yu X, Lan P, Hou X, Han Q, Lu N, Li T, Jiao C, Zhang J, Zhang C, Tian Z. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1\u03b2 production via suppressing the NF-\u03baB pathway and ROS production. J Hepatol. 2017;66:693\u2013702.","journal-title":"J Hepatol"},{"key":"4837_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12487","volume":"51","author":"N Chen","year":"2018","unstructured":"Chen N, Ou Z, Zhang W, Zhu X, Li P, Gong J. Cathepsin B regulates non-canonical NLRP3 inflammasome pathway by modulating activation of caspase-11 in Kupffer cells. Cell Prolif. 2018;51:e12487.","journal-title":"Cell Prolif"},{"key":"4837_CR115","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4837_CR116","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/SHK.0b013e31824a670b","volume":"37","author":"FA Gonnert","year":"2012","unstructured":"Gonnert FA, Kunisch E, Gajda M, Lambeck S, Weber M, Claus RA, Bauer M, Kinne RW. Hepatic fibrosis in a long-term murine model of sepsis. Shock. 2012;37:399\u2013407.","journal-title":"Shock"},{"key":"4837_CR117","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 2014;59:898\u2013910.","journal-title":"Hepatology"},{"key":"4837_CR118","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2010020143","volume":"21","author":"A Vilaysane","year":"2010","unstructured":"Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010;21:1732\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"4837_CR119","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41418-021-00755-6","volume":"28","author":"Y Li","year":"2021","unstructured":"Li Y, Yuan Y, Huang ZX, Chen H, Lan R, Wang Z, Lai K, Chen H, Chen Z, Zou Z, Ma HB, Lan HY, Mak TW, Xu Y. GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy. Cell Death Differ. 2021;28:2333\u201350.","journal-title":"Cell Death Differ"},{"key":"4837_CR120","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion. J Clin Invest. 2013;123:236\u201346.","journal-title":"J Clin Invest"},{"key":"4837_CR121","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000499685","volume":"44","author":"Z Ye","year":"2019","unstructured":"Ye Z, Zhang L, Li R, Dong W, Liu S, Li Z, Liang H, Wang L, Shi W, Malik AB, Cheng KT, Liang X. Caspase-11 mediates pyroptosis of tubular epithelial cells and septic acute kidney injury. Kidney Blood Press Res. 2019;44:465\u201378.","journal-title":"Kidney Blood Press Res"},{"key":"4837_CR122","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1038\/s41418-020-0524-1","volume":"27","author":"H Chen","year":"2020","unstructured":"Chen H, Li Y, Wu J, Li G, Tao X, Lai K, Yuan Y, Zhang X, Zou Z, Xu Y. RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis. Cell Death Differ. 2020;27:2568\u201385.","journal-title":"Cell Death Differ"},{"key":"4837_CR123","doi-asserted-by":"publisher","first-page":"663216","DOI":"10.3389\/fphys.2021.663216","volume":"12","author":"J Deng","year":"2021","unstructured":"Deng J, Tan W, Luo Q, Lin L, Zheng L, Yang J. Long non-coding RNA MEG3 promotes renal tubular epithelial cell pyroptosis by regulating the miR-18a-3p\/GSDMD pathway in Lipopolysaccharide-Induced acute kidney injury. Front Physiol. 2021;12:663216.","journal-title":"Front Physiol"},{"key":"4837_CR124","doi-asserted-by":"publisher","first-page":"18509","DOI":"10.1002\/jcb.29173","volume":"120","author":"Y Yao","year":"2019","unstructured":"Yao Y, Hu X, Feng X, Zhao Y, Song M, Wang C, Fan H. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4\/NOX4\/NF-\u03baB pathway. J Cell Biochem. 2019;120:18509\u201323.","journal-title":"J Cell Biochem"},{"key":"4837_CR125","doi-asserted-by":"publisher","first-page":"6636621","DOI":"10.1155\/2021\/6636621","volume":"2021","author":"M Yang","year":"2021","unstructured":"Yang M, Fang JT, Zhang NS, Qin LJ, Zhuang YY, Wang WW, Zhu HP, Zhang YJ, Xia P, Zhang Y. Caspase-1-Inhibitor AC-YVAD-CMK inhibits pyroptosis and ameliorates acute kidney injury in a model of sepsis. Biomed Res Int. 2021;2021:6636621.","journal-title":"Biomed Res Int"},{"key":"4837_CR126","doi-asserted-by":"publisher","first-page":"9152140","DOI":"10.1155\/2020\/9152140","volume":"2020","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Y, Liu Q, Zheng Q, Dong X, Liu X, Gao W, Bai X, Li Z. Caspase-1-Dependent pyroptosis of peripheral blood mononuclear cells is associated with the severity and mortality of septic patients. Biomed Res Int. 2020;2020:9152140.","journal-title":"Biomed Res Int"},{"key":"4837_CR127","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.2147\/DDDT.S334518","volume":"15","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang Y, Yang A, Xia F. Downregulation of IRF2 alleviates Sepsis-Related acute kidney injury in vitro and in vivo. Drug Des Devel Ther. 2021;15:5123\u201332.","journal-title":"Drug Des Devel Ther"},{"key":"4837_CR128","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41419-021-03431-2","volume":"12","author":"W Xia","year":"2021","unstructured":"Xia W, Li Y, Wu M, Jin Q, Wang Q, Li S, Huang S, Zhang A, Zhang Y, Jia Z. Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell Death Dis. 2021;12:139.","journal-title":"Cell Death Dis"},{"key":"4837_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110800","volume":"124","author":"Y Hong","year":"2023","unstructured":"Hong Y, Chen P, Gao J, Lin Y, Chen L, Shang X. Sepsis-associated encephalopathy: from pathophysiology to clinical management. Int Immunopharmacol. 2023;124:110800.","journal-title":"Int Immunopharmacol"},{"key":"4837_CR130","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10753-018-0894-4","volume":"42","author":"Q Fu","year":"2019","unstructured":"Fu Q, Wu J, Zhou XY, Ji MH, Mao QH, Li Q, et al. NLRP3\/caspase-1 pathway-induced pyroptosis mediated cognitive deficits in a mouse model of sepsis-associated encephalopathy. Inflammation. 2019;42:306\u201318.","journal-title":"Inflammation"},{"key":"4837_CR131","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-020-1728-5","volume":"17","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Wang Y, Zhou R, Li Y, Gao Y, Tu D, Wilson B, Song S, Feng J, Hong JS, Yakel JL. A novel role of NLRP3-generated IL-1\u03b2 in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration. J Neuroinflammation. 2020;17:64.","journal-title":"J Neuroinflammation"},{"key":"4837_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810269","author":"DA Machtens","year":"2022","unstructured":"Machtens DA, Bresch IP, Eberhage J, Reubold TF, Eschenburg S. The inflammasome activity of NLRP3 is independent of NEK7 in HEK293 cells co-expressing ASC. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231810269.","journal-title":"Int J Mol Sci"},{"key":"4837_CR133","doi-asserted-by":"publisher","first-page":"572136","DOI":"10.3389\/fimmu.2020.572136","volume":"11","author":"MT Islam","year":"2020","unstructured":"Islam MT, Bardaweel SK, Mubarak MS, Koch W, Gawe\u0142-Beben K, Antosiewicz B, et al. Immunomodulatory effects of diterpenes and their derivatives through NLRP3 inflammasome pathway: a review. Front Immunol. 2020;11:572136.","journal-title":"Front Immunol"},{"key":"4837_CR134","doi-asserted-by":"publisher","first-page":"594071","DOI":"10.3389\/fimmu.2020.594071","volume":"11","author":"S Chen","year":"2020","unstructured":"Chen S, Tang C, Ding H, Wang Z, Liu X, Chai Y, Jiang W, Han Y, Zeng H. Maf1 ameliorates Sepsis-Associated encephalopathy by suppressing the NF-kB\/NLRP3 inflammasome signaling pathway. Front Immunol. 2020;11:594071.","journal-title":"Front Immunol"},{"key":"4837_CR135","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fphys.2018.00313","volume":"9","author":"EJ Kim","year":"2018","unstructured":"Kim EJ, Park SY, Baek SE, Jang MA, Lee WS, Bae SS, Kim K, Kim CD. HMGB1 increases IL-1\u03b2 production in vascular smooth muscle cells via NLRP3 inflammasome. Front Physiol. 2018;9:313.","journal-title":"Front Physiol"},{"key":"4837_CR136","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1750-3639.2001.tb00399.x","volume":"11","author":"M von Mering","year":"2001","unstructured":"von Mering M, Wellmer A, Michel U, Bunkowski S, T\u0142ustochowska A, Br\u00fcck W, et al. Transcriptional regulation of caspases in experimental pneumococcal meningitis. Brain Pathol. 2001;11:282\u201395.","journal-title":"Brain Pathol"},{"key":"4837_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147109","volume":"1748","author":"X Sun","year":"2020","unstructured":"Sun X, Zhou R, Lei Y, Hu J, Li X. The ligand-gated ion channel P2X7 receptor mediates NLRP3\/caspase-1-mediated pyroptosis in cerebral cortical neurons of juvenile rats with sepsis. Brain Res. 2020;1748:147109.","journal-title":"Brain Res"},{"key":"4837_CR138","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00011-020-01347-9","volume":"69","author":"K Xie","year":"2020","unstructured":"Xie K, Zhang Y, Wang Y, Meng X, Wang Y, Yu Y, Chen H. Hydrogen attenuates sepsis-associated encephalopathy by NRF2 mediated NLRP3 pathway inactivation. Inflamm Res. 2020;69:697\u2013710.","journal-title":"Inflamm Res"},{"key":"4837_CR139","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12974-019-1651-9","volume":"16","author":"R Zhou","year":"2019","unstructured":"Zhou R, Yang X, Li X, Qu Y, Huang Q, Sun X, Mu D. Recombinant CC16 inhibits NLRP3\/caspase-1-induced pyroptosis through p38 MAPK and ERK signaling pathways in the brain of a neonatal rat model with sepsis. J Neuroinflammation. 2019;16:239.","journal-title":"J Neuroinflammation"},{"key":"4837_CR140","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainresbull.2022.09.007","volume":"189","author":"X Zhong","year":"2022","unstructured":"Zhong X, Chen Z, Wang Y, Mao M, Deng Y, Shi M, Xu Y, Chen L, Cao W. JQ1 attenuates neuroinflammation by inhibiting the inflammasome-dependent canonical pyroptosis pathway in SAE. Brain Res Bull. 2022;189:174\u201383.","journal-title":"Brain Res Bull"},{"key":"4837_CR141","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fncel.2020.00251","volume":"14","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Yin L, Cheng X, Li J, Wu H, Liu X, Gu E, Wu J. Elamipretide attenuates pyroptosis and perioperative neurocognitive disorders in aged mice. Front Cell Neurosci. 2020;14:251.","journal-title":"Front Cell Neurosci"},{"key":"4837_CR142","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/WNR.0000000000001882","volume":"34","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Fu Q, Ruan J, Shi C, Lu W, Wu J, et al. Dexpramipexole ameliorates cognitive deficits in sepsis-associated encephalopathy through suppressing mitochondria-mediated pyroptosis and apoptosis. Neuroreport. 2023;34:220\u201331.","journal-title":"Neuroreport"},{"key":"4837_CR143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-019-1416-5","volume":"10","author":"YB Sun","year":"2019","unstructured":"Sun YB, Zhao H, Mu DL, Zhang W, Cui J, Wu L, Alam A, Wang DX, Ma D. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis. 2019;10:167.","journal-title":"Cell Death Dis"},{"key":"4837_CR144","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(16)30119-4","volume":"2","author":"BW Haak","year":"2017","unstructured":"Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol. 2017;2:135\u201343.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4837_CR145","doi-asserted-by":"publisher","first-page":"2221470","DOI":"10.1080\/19490976.2023.2221470","volume":"15","author":"JW Duess","year":"2023","unstructured":"Duess JW, Sampah ME, Lopez CM, Tsuboi K, Scheese DJ, Sodhi CP, Hackam DJ. Necrotizing enterocolitis, gut microbes, and sepsis. Gut Microbes. 2023;15:2221470.","journal-title":"Gut Microbes"},{"key":"4837_CR146","doi-asserted-by":"publisher","first-page":"609319","DOI":"10.3389\/fimmu.2021.609319","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Zhong X, Cao W, Mao M, Li W, Yang H, et al. JQ1 as a BRD4 inhibitor blocks inflammatory pyroptosis-related acute colon injury induced by LPS. Front Immunol. 2021;12:609319.","journal-title":"Front Immunol"},{"key":"4837_CR147","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10620-017-4801-x","volume":"63","author":"XY Zhang","year":"2018","unstructured":"Zhang XY, Chen X, Zhang HF, Guan S, Wen SH, Huang WQ, Liu ZM. Propofol does not reduce pyroptosis of enterocytes and intestinal epithelial injury after lipopolysaccharide challenge. Dig Dis Sci. 2018;63:81\u201391.","journal-title":"Dig Dis Sci"},{"key":"4837_CR148","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00134-024-07507-3","volume":"50","author":"F Meziani","year":"2024","unstructured":"Meziani F, Iba T, Levy JH, Helms J. Sepsis-induced coagulopathy: a matter of timeline. Intensive Care Med. 2024;50:1404\u20135.","journal-title":"Intensive Care Med"},{"key":"4837_CR149","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","volume":"132","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology. 2020;132:1238\u201345.","journal-title":"Anesthesiology"},{"key":"4837_CR150","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00134-024-07586-2","volume":"50","author":"M Girardis","year":"2024","unstructured":"Girardis M, David S, Ferrer R, Helms J, Juffermans NP, Martin-Loeches I, Povoa P, Russell L, Shankar-Hari M, Iba T, Coloretti I, Parchim N, Nielsen ND. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis. Intensive Care Med. 2024;50:1580\u201392.","journal-title":"Intensive Care Med"},{"key":"4837_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.005","volume":"222","author":"L Luo","year":"2020","unstructured":"Luo L, Xu M, Liao D, Deng J, Mei H, Hu Y. PECAM-1 protects against DIC by dampening inflammatory responses via inhibiting macrophage pyroptosis and restoring vascular barrier integrity. Transl Res. 2020;222:1\u201316.","journal-title":"Transl Res"},{"key":"4837_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00483-w","volume":"6","author":"C Yuan","year":"2021","unstructured":"Yuan C, Wu M, Xiao Q, Zhao W, Li H, Zhong Y, et al. Blocking Msr1 by berberine alkaloids inhibits caspase-11-dependent coagulation in bacterial sepsis. Signal Transduct Target Ther. 2021;6:92.","journal-title":"Signal Transduct Target Ther"},{"key":"4837_CR153","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2019.11.005","volume":"51","author":"X Yang","year":"2019","unstructured":"Yang X, Cheng X, Tang Y, Qiu X, Wang Y, Kang H, et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity. 2019;51:983-996.e986.","journal-title":"Immunity"},{"key":"4837_CR154","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/stem.3016","volume":"37","author":"A Andrzejewska","year":"2019","unstructured":"Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells. 2019;37:855\u201364.","journal-title":"Stem Cells"},{"key":"4837_CR155","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230\u201347.","journal-title":"Transplantation"},{"key":"4837_CR156","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev-cellbio-100913-013132","volume":"30","author":"P Bianco","year":"2014","unstructured":"Bianco P. Mesenchymal stem cells. Annu Rev Cell Dev Biol. 2014;30:677\u2013704.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4837_CR157","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/thoraxjnl-2012-201923","volume":"67","author":"S Rankin","year":"2012","unstructured":"Rankin S. Mesenchymal stem cells. Thorax. 2012;67:565\u20136.","journal-title":"Thorax"},{"key":"4837_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53:e12712.","journal-title":"Cell Prolif"},{"key":"4837_CR159","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1177\/0022034519862258","volume":"98","author":"V Yianni","year":"2019","unstructured":"Yianni V, Sharpe PT. Perivascular-derived mesenchymal stem cells. J Dent Res. 2019;98:1066\u201372.","journal-title":"J Dent Res"},{"key":"4837_CR160","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"4837_CR161","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"4837_CR162","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13287-020-01855-9","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther. 2020;11:345.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR163","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13287-023-03497-z","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Gao T, Wang B. Application of mesenchymal stem cells for anti-senescence and clinical challenges. Stem Cell Res Ther. 2023;14:260.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR164","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s10020-024-00967-9","volume":"30","author":"Q Xu","year":"2024","unstructured":"Xu Q, Hou W, Zhao B, Fan P, Wang S, Wang L, Gao J. Mesenchymal stem cells lineage and their role in disease development. Mol Med. 2024;30:207.","journal-title":"Mol Med"},{"key":"4837_CR165","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","volume":"31","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringd\u00e9n O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31:890\u20136.","journal-title":"Exp Hematol"},{"key":"4837_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202403199","volume":"36","author":"Y Xia","year":"2024","unstructured":"Xia Y, Zhang J, Liu G, Wolfram J. Immunogenicity of extracellular vesicles. Adv Mater. 2024;36:e2403199.","journal-title":"Adv Mater"},{"key":"4837_CR167","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5966\/sctm.2016-0044","volume":"6","author":"JA Zimmermann","year":"2017","unstructured":"Zimmermann JA, Hettiaratchi MH, McDevitt TC. Enhanced immunosuppression of T cells by sustained presentation of bioactive Interferon-\u03b3 within Three-Dimensional mesenchymal stem cell constructs. Stem Cells Transl Med. 2017;6:223\u201337.","journal-title":"Stem Cells Transl Med"},{"key":"4837_CR168","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10517-016-3461-8","volume":"161","author":"KN Yarygin","year":"2016","unstructured":"Yarygin KN, Lupatov AY, Sukhikh GT. Modulation of immune responses by mesenchymal stromal cells. Bull Exp Biol Med. 2016;161:561\u20135.","journal-title":"Bull Exp Biol Med"},{"key":"4837_CR169","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","volume":"6","author":"JD Glenn","year":"2014","unstructured":"Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cells. 2014;6:526\u201339.","journal-title":"World J Stem Cells"},{"key":"4837_CR170","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1002\/jcp.27298","volume":"234","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Halabian R, Fooladi AAI. Antimicrobial effects of mesenchymal stem cells primed by modified LPS on bacterial clearance in sepsis. J Cell Physiol. 2019;234:4970\u201386.","journal-title":"J Cell Physiol"},{"key":"4837_CR171","doi-asserted-by":"publisher","first-page":"156173","DOI":"10.1016\/j.phymed.2024.156173","volume":"135","author":"Q Yu","year":"2024","unstructured":"Yu Q, Zhang L, Wang Z, Wang Q, Sun X, Deng W, Cao X, Yu J, Xu X. Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis. Phytomedicine. 2024;135:156173.","journal-title":"Phytomedicine"},{"key":"4837_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104840","volume":"401","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang Z, Sun X, Rong W, Deng W, Yu J, et al. Nasal mucosa-derived mesenchymal stem cells prolonged the survival of septic rats by protecting macrophages from pyroptosis. Cell Immunol. 2024;401:104840.","journal-title":"Cell Immunol"},{"key":"4837_CR173","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/340257","volume":"2014","author":"B Usunier","year":"2014","unstructured":"Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int. 2014;2014:340257.","journal-title":"Stem Cells Int"},{"key":"4837_CR174","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejvs.2017.10.012","volume":"55","author":"C Wang","year":"2018","unstructured":"Wang C, Li Y, Yang M, Zou Y, Liu H, Liang Z, Yin Y, Niu G, Yan Z, Zhang B. Efficient differentiation of bone marrow mesenchymal stem cells into endothelial cells in vitro. Eur J Vasc Endovasc Surg. 2018;55:257\u201365.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"4837_CR175","doi-asserted-by":"crossref","unstructured":"Zhang Y, Babczyk P, Pansky A, Kassack MU, Tobiasch E (2020) P2 receptors influence hMSCs differentiation towards endothelial cell and smooth muscle cell lineages. Int J Mol Sci. 21: 6210.","DOI":"10.3390\/ijms21176210"},{"key":"4837_CR176","doi-asserted-by":"publisher","first-page":"e37512","DOI":"10.1371\/journal.pone.0037512","volume":"7","author":"C Sassoli","year":"2012","unstructured":"Sassoli C, Pini A, Chellini F, Mazzanti B, Nistri S, Nosi D, et al. Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS One. 2012;7:e37512.","journal-title":"PLoS One"},{"key":"4837_CR177","doi-asserted-by":"publisher","first-page":"66","DOI":"10.22203\/eCM.v026a05","volume":"26","author":"K Grote","year":"2013","unstructured":"Grote K, Petri M, Liu C, Jehn P, Spalthoff S, Kokem\u00fcller H, Luchtefeld M, Tschernig T, Krettek C, Haasper C, Jagodzinski M. Toll-like receptor 2\/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors. Eur Cell Mater. 2013;26:66\u201379. discussion 79.","journal-title":"Eur Cell Mater"},{"key":"4837_CR178","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther. 2016;7:125.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR179","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13287-025-04158-z","volume":"16","author":"A Hoseinzadeh","year":"2025","unstructured":"Hoseinzadeh A, Esmaeili SA, Sahebi R, Melak AM, Mahmoudi M, Hasannia M, Baharlou R. Fate and long-lasting therapeutic effects of mesenchymal stromal\/stem-like cells: mechanistic insights. Stem Cell Res Ther. 2025;16:33.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR180","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11274-023-03725-x","volume":"39","author":"M Bicer","year":"2023","unstructured":"Bicer M, Fidan O. Can mesenchymal stem\/stromal cells and their secretomes combat bacterial persisters? World J Microbiol Biotechnol. 2023;39:276.","journal-title":"World J Microbiol Biotechnol"},{"key":"4837_CR181","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13287-020-01807-3","volume":"11","author":"H Yagi","year":"2020","unstructured":"Yagi H, Chen AF, Hirsch D, Rothenberg AC, Tan J, Alexander PG, et al. Antimicrobial activity of mesenchymal stem cells against Staphylococcus aureus. Stem Cell Res Ther. 2020;11:293.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR182","doi-asserted-by":"crossref","unstructured":"Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y, Xie Z, Zhang X. Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets, MedComm (2020), 5 (2024) e70024.","DOI":"10.1002\/mco2.70024"},{"key":"4837_CR183","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13054-025-05278-x","volume":"29","author":"Y Wang","year":"2025","unstructured":"Wang Y, Weng L, Wu X, Du B. The role of programmed cell death in organ dysfunction induced by opportunistic pathogens. Crit Care. 2025;29:43.","journal-title":"Crit Care"},{"key":"4837_CR184","doi-asserted-by":"crossref","unstructured":"Wu HW, Chen HD, Chen YH, Mao XL, Feng YY, Li SW, Zhou XB. The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis, Stem Cells Int, 2023 (2023) 4586398.","DOI":"10.1155\/2023\/4586398"},{"key":"4837_CR185","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13287-025-04193-w","volume":"16","author":"P Hassanpour","year":"2025","unstructured":"Hassanpour P, Sadeghsoltani F, Saghebasl S, Boroumand S, Khanicheragh P, Tafti SHA, Rahbarghazi R, Rahmati M. Mitochondrial transplantation for cardioprotection and induction of angiogenesis in ischemic heart disease. Stem Cell Res Ther. 2025;16:54.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR186","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1242\/jcs.200667","volume":"130","author":"TM Ribeiro-Rodrigues","year":"2017","unstructured":"Ribeiro-Rodrigues TM, Martins-Marques T, Morel S, Kwak BR, Gir\u00e3o H. Role of connexin 43 in different forms of intercellular communication - gap junctions, extracellular vesicles and tunnelling nanotubes. J Cell Sci. 2017;130:3619\u201330.","journal-title":"J Cell Sci"},{"key":"4837_CR187","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12964-022-00931-2","volume":"20","author":"Z Feng","year":"2022","unstructured":"Feng Z, Hua S, Li W, Han J, Li F, Chen H, Zhang Z, Xie Y, Ouyang Q, Zou X, Liu Z, Li C, Huang S, Lai Z, Cai X, Cai Y, Zou Y, Tang Y, Jiang X. Mesenchymal stem cells protect against TBI-induced pyroptosis in vivo and in vitro through TSG-6. Cell Commun Signal. 2022;20:125.","journal-title":"Cell Commun Signal"},{"key":"4837_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012065","volume":"23","author":"C Piao","year":"2022","unstructured":"Piao C, Sang J, Kou Z, Wang Y, Liu T, Lu X, et al. Effects of exosomes derived from adipose-derived mesenchymal stem cells on pyroptosis and regeneration of injured liver. Int J Mol Sci. 2022;23:12065.","journal-title":"Int J Mol Sci"},{"key":"4837_CR189","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney DG, Prockop DJ. Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2013current views. Stem Cells. 2007;25:2896\u2013902.","journal-title":"Stem Cells"},{"key":"4837_CR190","doi-asserted-by":"crossref","unstructured":"Fraile M, Eiro N, Costa LA, Mart\u00edn A, Vizoso FJ. Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies, Biology (Basel), 11 (2022).","DOI":"10.3390\/biology11111678"},{"key":"4837_CR191","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.stem.2008.01.014","volume":"2","author":"BD Humphreys","year":"2008","unstructured":"Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, McMahon AP, Bonventre JV. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008;2:284\u201391.","journal-title":"Cell Stem Cell"},{"key":"4837_CR192","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.scr.2008.02.002","volume":"1","author":"L Timmers","year":"2007","unstructured":"Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2007;1:129\u201337.","journal-title":"Stem Cell Res"},{"key":"4837_CR193","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res. 2010;4:214\u201322.","journal-title":"Stem Cell Res"},{"key":"4837_CR194","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-021-00736-4","volume":"28","author":"J Janockova","year":"2021","unstructured":"Janockova J, Slovinska L, Harvanova D, Spakova T, Rosocha J. New therapeutic approaches of mesenchymal stem cells-derived exosomes. J Biomed Sci. 2021;28:39.","journal-title":"J Biomed Sci"},{"key":"4837_CR195","doi-asserted-by":"publisher","first-page":"1136964","DOI":"10.3389\/fimmu.2023.1136964","volume":"14","author":"K Homma","year":"2023","unstructured":"Homma K, Bazhanov N, Hashimoto K, Shimizu M, Heathman T, Hao Q, Nawgiri R, Muthukumarana V, Lee JW, Prough DS, Enkhbaatar P. Mesenchymal stem cell-derived exosomes for treatment of sepsis. Front Immunol. 2023;14:1136964.","journal-title":"Front Immunol"},{"key":"4837_CR196","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13036-024-00431-6","volume":"18","author":"D Huang","year":"2024","unstructured":"Huang D, Shen H, Xie F, Hu D, Jin Q, Hu Y, Zhong T. Role of mesenchymal stem cell-derived exosomes in the regeneration of different tissues. J Biol Eng. 2024;18:36.","journal-title":"J Biol Eng"},{"key":"4837_CR197","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","volume":"12","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther. 2021;12:71.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115167","volume":"203","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Nejati V, Mahmoodi M, Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: a promising nanomedicine for drug delivery system. Biochem Pharmacol. 2022;203:115167.","journal-title":"Biochem Pharmacol"},{"key":"4837_CR199","doi-asserted-by":"crossref","unstructured":"R. Palmulli, G. van Niel, To be or not to be\u2026 secreted as exosomes, a balance finely tuned by the mechanisms of biogenesis, Essays Biochem, 62 (2018) 177\u2013191.","DOI":"10.1042\/EBC20170076"},{"key":"4837_CR200","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40364-019-0159-x","volume":"7","author":"K Yin","year":"2019","unstructured":"Yin K, Wang S, Zhao RC. Exosomes from mesenchymal stem\/stromal cells: a new therapeutic paradigm. Biomark Res. 2019;7:8.","journal-title":"Biomark Res"},{"key":"4837_CR201","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12010-022-04090-5","volume":"195","author":"X He","year":"2023","unstructured":"He X, Zhang C, Amirsaadat S, Jalil AT, Kadhim MM, Abasi M, et al. Curcumin-loaded mesenchymal stem cell-derived exosomes efficiently attenuate proliferation and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Appl Biochem Biotechnol. 2023;195:51\u201367.","journal-title":"Appl Biochem Biotechnol"},{"key":"4837_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113953","volume":"349","author":"TT Tan","year":"2022","unstructured":"Tan TT, Toh WS, Lai RC, Lim SK. Practical considerations in transforming MSC therapy for neurological diseases from cell to EV. Exp Neurol. 2022;349:113953.","journal-title":"Exp Neurol"},{"key":"4837_CR203","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12238","volume":"11","author":"A G\u00f6rgens","year":"2022","unstructured":"G\u00f6rgens A, Corso G, Hagey DW, Wiklander R. Jawad, Gustafsson MO, Felldin U, et al. Identification of storage conditions stabilizing extracellular vesicles preparations. J Extracell Vesicles. 2022;11:e12238.","journal-title":"J Extracell Vesicles"},{"key":"4837_CR204","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/nyas.13102","volume":"1370","author":"H Li","year":"2016","unstructured":"Li H, Ghazanfari R, Zacharaki D, Lim HC, Scheding S. Isolation and characterization of primary bone marrow mesenchymal stromal cells. Ann N Y Acad Sci. 2016;1370:109\u201318.","journal-title":"Ann N Y Acad Sci"},{"key":"4837_CR205","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s12015-020-10006-9","volume":"16","author":"A Jaukovi\u0107","year":"2020","unstructured":"Jaukovi\u0107 A, Abadjieva D, Trivanovi\u0107 D, Stoyanova E, Kostadinova M, Pashova S, Kestendjieva S, Kukolj T, Jeseta M, Kistanova E, Mourdjeva M. Specificity of 3D MSC spheroids microenvironment: impact on MSC behavior and properties. Stem Cell Rev Rep. 2020;16:853\u201375.","journal-title":"Stem Cell Rev Rep"},{"key":"4837_CR206","doi-asserted-by":"crossref","unstructured":"Guy R, Offen D. Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes, Biomolecules, 10 (2020).","DOI":"10.3390\/biom10091320"},{"key":"4837_CR207","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12964-022-01017-9","volume":"21","author":"E Oveili","year":"2023","unstructured":"Oveili E, Vafaei S, Bazavar H, Eslami Y, Mamaghanizadeh E, Yasamineh S, Gholizadeh O. The potential use of mesenchymal stem cells-derived exosomes as MicroRNAs delivery systems in different diseases. Cell Commun Signal. 2023;21:20.","journal-title":"Cell Commun Signal"},{"key":"4837_CR208","doi-asserted-by":"crossref","unstructured":"Niu X, Zhang L, Xing S, Liu J, Li D, Wang Y, Wang Y, Su M. Targeting lung damage: amniotic mesenchymal stem cells mitigate Lipopolysaccharide-Induced acute lung injury via multiple signaling pathways. Int J Mol Sci, 26 (2025).","DOI":"10.3390\/ijms26052314"},{"key":"4837_CR209","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13287-024-03977-w","volume":"15","author":"S Regmi","year":"2024","unstructured":"Regmi S, Ganguly A, Pathak S, Primavera R, Chetty S, Wang J, Patel S, Thakor AS. Evaluating the therapeutic potential of different sources of mesenchymal stem cells in acute respiratory distress syndrome. Stem Cell Res Ther. 2024;15:385.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR210","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1518008","volume":"15","author":"K Lv","year":"2024","unstructured":"Lv K, Liang Q. Macrophages in sepsis-induced acute lung injury: exosomal modulation and therapeutic potential. Front Immunol. 2024;15:1518008.","journal-title":"Front Immunol"},{"key":"4837_CR211","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/stcltm\/szad094","volume":"13","author":"P Liu","year":"2024","unstructured":"Liu P, Yang S, Shao X, Li C, Wang Z, Dai H, et al. Mesenchymal stem cells-derived exosomes alleviate acute lung injury by inhibiting alveolar macrophage pyroptosis. Stem Cells Transl Med. 2024;13:371\u201386.","journal-title":"Stem Cells Transl Med"},{"key":"4837_CR212","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.2147\/IJN.S441133","volume":"18","author":"Y Tao","year":"2023","unstructured":"Tao Y, Xu X, Yang B, Zhao H, Li Y. Mitigation of Sepsis-induced acute lung injury by BMSC-derived exosomal miR-125b-5p through STAT3-mediated suppression of macrophage pyroptosis. Int J Nanomed. 2023;18:7095\u2013113.","journal-title":"Int J Nanomed"},{"key":"4837_CR213","doi-asserted-by":"crossref","unstructured":"Liu X, Gao C, Wang Y, Niu L, Jiang S, Pan S. BMSC-Derived Exosomes Ameliorate LPS-Induced Acute Lung Injury by miR-384-5p-Controlled Alveolar Macrophage Autophagy, Oxid Med Cell Longev, 2021 (2021) 9973457.","DOI":"10.1155\/2021\/9973457"},{"key":"4837_CR214","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2147\/IJN.S498770","volume":"20","author":"T Li","year":"2025","unstructured":"Li T, Zhao Y, Cao Z, Shen Y, Chen J, Huang X, et al. Exosomes derived from Apelin-pretreated mesenchymal stem cells ameliorate Sepsis-induced myocardial dysfunction by alleviating cardiomyocyte pyroptosis via delivery of miR-34a-5p. Int J Nanomed. 2025;20:687\u2013703.","journal-title":"Int J Nanomed"},{"key":"4837_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108910","volume":"110","author":"L Pan","year":"2022","unstructured":"Pan L, Yan B, Zhang J, Zhao P, Jing Y, Yu J, et al. Mesenchymal stem cells-derived extracellular vesicles-shuttled microRNA-223-3p suppress lipopolysaccharide-induced cardiac inflammation, pyroptosis, and dysfunction. Int Immunopharmacol. 2022;110:108910.","journal-title":"Int Immunopharmacol"},{"key":"4837_CR216","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4252\/wjsc.v15.i7.654","volume":"15","author":"LF Pan","year":"2023","unstructured":"Pan LF, Niu ZQ, Ren S, Pei HH, Gao YX, Feng H, Sun JL, Zhang ZL. Could extracellular vesicles derived from mesenchymal stem cells be a potential therapy for acute pancreatitis-induced cardiac injury? World J Stem Cells. 2023;15:654\u201364.","journal-title":"World J Stem Cells"},{"key":"4837_CR217","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1574888X17666220407103441","volume":"17","author":"Y Yin","year":"2022","unstructured":"Yin Y, Tang L, Liu K, Ding X, Wang D, Chen L. Attenuation of lipopolysaccharide-induced liver injury by bone marrow mesenchymal stem cells via inhibiting the NLRP3 inflammasome and hepatocyte pyroptosis. Curr Stem Cell Res Ther. 2022;17:361\u20139.","journal-title":"Curr Stem Cell Res Ther"},{"key":"4837_CR218","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/hep.32129","volume":"75","author":"A Psaraki","year":"2022","unstructured":"Psaraki A, Ntari L, Karakostas C, Korrou-Karava D, Roubelakis MG. Extracellular vesicles derived from mesenchymal stem\/stromal cells: the regenerative impact in liver diseases. Hepatology. 2022;75:1590\u2013603.","journal-title":"Hepatology"},{"key":"4837_CR219","doi-asserted-by":"publisher","first-page":"111575","DOI":"10.1016\/j.intimp.2024.111575","volume":"128","author":"L Pei","year":"2024","unstructured":"Pei L, Li R, Wang X, Xu D, Gong F, Chen W, Zheng X, Liu W, Zhao S, Wang Q, Mao E, Chen E, Chen Y, Yang Z. MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction by inhibiting macrophage glycolysis-mediated inflammatory response. Int Immunopharmacol. 2024;128:111575.","journal-title":"Int Immunopharmacol"},{"key":"4837_CR220","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s42003-024-06236-z","volume":"7","author":"Y Ma","year":"2024","unstructured":"Ma Y, She X, Liu Y, Qin X. MSC-derived exosomal miR-140-3p improves cognitive dysfunction in sepsis-associated encephalopathy by HMGB1 and S-lactoylglutathione metabolism. Commun Biol. 2024;7:562.","journal-title":"Commun Biol"},{"key":"4837_CR221","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12951-022-01522-6","volume":"20","author":"T Hua","year":"2022","unstructured":"Hua T, Yang M, Song H, Kong E, Deng M, Li Y, Li J, Liu Z, Fu H, Wang Y, Yuan H. Huc-MSCs-derived exosomes attenuate inflammatory pain by regulating microglia pyroptosis and autophagy via the miR-146a-5p\/TRAF6 axis. J Nanobiotechnol. 2022;20:324.","journal-title":"J Nanobiotechnol"},{"key":"4837_CR222","doi-asserted-by":"crossref","unstructured":"Wang C, Zhang J, Chen W, Gao L, He J, Xia Y. Exosomal LncRNA RMRP-shuttled by olfactory Mucosa-Mesenchymal stem cells suppresses microglial pyroptosis to improve spinal cord injury via EIF4A3\/SIRT1. Mol Neurobiol; 2025.","DOI":"10.1007\/s12035-025-04756-1"},{"key":"4837_CR223","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00011-022-01653-4","volume":"72","author":"Z Xie","year":"2023","unstructured":"Xie Z, Tang J, Chen Z, Wei L, Chen J, Liu Q. Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p\/HDAC2\/SNRK. Inflamm Res. 2023;72:553\u201376.","journal-title":"Inflamm Res"},{"key":"4837_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.639165","volume":"12","author":"J Guo","year":"2021","unstructured":"Guo J, Wang R, Liu D. Bone marrow-derived mesenchymal stem cells ameliorate sepsis-induced acute kidney injury by promoting mitophagy of renal tubular epithelial cells via the SIRT1\/Parkin axis. Front Endocrinol (Lausanne). 2021;12:639165.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4837_CR225","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.7150\/thno.54550","volume":"11","author":"JY Cao","year":"2021","unstructured":"Cao JY, Wang B, Tang TT, Wen Y, Li ZL, Feng ST, Wu M, Liu D, Yin D, Ma KL, Tang RN, Wu QL, Lan HY, Lv LL, Liu BC. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11:5248\u201366.","journal-title":"Theranostics"},{"key":"4837_CR226","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00011-022-01577-z","volume":"71","author":"D Wang","year":"2022","unstructured":"Wang D, Xue H, Tan J, Liu P, Qiao C, Pang C, Zhang L. Bone marrow mesenchymal stem cells-derived exosomes containing miR-539-5p inhibit pyroptosis through NLRP3\/caspase-1 signalling to alleviate inflammatory bowel disease. Inflamm Res. 2022;71:833\u201346.","journal-title":"Inflamm Res"},{"key":"4837_CR227","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ymthe.2023.12.008","volume":"32","author":"W Huang","year":"2024","unstructured":"Huang W, Wang B, Ou Q, Zhang X, He Y, Mao X, Wei X, Kou X. ASC-expressing pyroptotic extracellular vesicles alleviate sepsis by protecting B cells. Mol Ther. 2024;32:395\u2013410.","journal-title":"Mol Ther"},{"key":"4837_CR228","doi-asserted-by":"publisher","DOI":"10.1039\/D4BM01505C","author":"Q Wu","year":"2025","unstructured":"Wu Q, Liu S, Zhao M, Wang Y, Lv K, Zhu J, et al. Pyroptosis-preconditioned mesenchymal stromal cell-derived extracellular vesicles as advanced nanomedicines for treating inflammatory diseases. Biomater Sci. 2025. https:\/\/doi.org\/10.1039\/D4BM01505C.","journal-title":"Biomater Sci"},{"key":"4837_CR229","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12967-023-04121-7","volume":"21","author":"S Yang","year":"2023","unstructured":"Yang S, Zhang K, Hou J, Liu X, Xu D, Chen X, Li S, Hong Y, Zhou C, Wu H, Zheng G, Zeng C, Wu H, Fu J, Wang T. Protective properties of extracellular vesicles in sepsis models: a systematic review and meta-analysis of preclinical studies. J Transl Med. 2023;21:262.","journal-title":"J Transl Med"},{"key":"4837_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098234","volume":"24","author":"NG Blanco","year":"2023","unstructured":"Blanco NG, Machado NM, Castro LL, Antunes MA, Takiya CM, Trugilho MRO, et al. Extracellular vesicles from different sources of mesenchymal stromal cells have distinct effects on lung and distal organs in experimental sepsis. Int J Mol Sci. 2023;24:8234.","journal-title":"Int J Mol Sci"},{"key":"4837_CR231","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13287-023-03402-8","volume":"14","author":"M Zarrabi","year":"2023","unstructured":"Zarrabi M, Shahrbaf MA, Nouri M, Shekari F, Hosseini S-E, Hashemian S-MR, et al. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial. Stem Cell Res Ther. 2023;14:169.","journal-title":"Stem Cell Res Ther"},{"key":"4837_CR232","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/cells13020122","volume":"13","author":"CC dos Santos","year":"2024","unstructured":"dos Santos CC, Lopes-Pacheco M, English K, Rolandsson Enes S, Krasnodembskaya A, Rocco PRM. The MSC-EV-microRNAome: a perspective on therapeutic mechanisms of action in sepsis and ARDS. Cells. 2024;13:122.","journal-title":"Cells"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04837-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:10:28Z","timestamp":1768342228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04837-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":232,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4837"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04837-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}